Marketplace / Biotech / Pre-Seed
HarmonIQ Biosciences
“Continuous hormone monitoring, on your body, in real time. The missing data layer for human health. ”
Open round — HarmonIQ Biosciences is raising $2.0M for its Pre-Seed
The founder is taking investor conversations now, and on PitchSpark you reach them directly — no warm intro, no gatekeeper. Create a free investor account to see the financials and the deck, then message the founder in one click.

Overview
I spent my career at the intersection of the three fields this device requires. I ran clinical trials for Class II and Class III medical devices, so I know the regulatory path and what design lock actually takes. I worked inside a wearable company collecting physiological data at scale. And I built infrastructure in clinical research technology. Continuous hormone monitoring sits exactly where those three meet, and very few people have stood in all three at once. What I kept seeing was the same gap. Hormones run reproduction, metabolism, stress, and aging, yet every decision gets made from a single blood draw at one random moment. The data simply doesn't exist, because no one has built the hardware to capture it continuously. So we are. I assembled a team that has done the hard version of this before: leaders out of the continuous glucose monitoring industry who have taken wearable biosensors from bench to body, and aptamer chemists who build the sensing layer. We know what it takes to move a biosensor from a working electrode to a device people wear, because we've done it for glucose. Now we're doing it for hormones.
Traction
as reported by the founder14 LOIs 3 Accelerators BARDA Relationship
Pitch deck
The founder has published a deck
Sign in free to read it and request data-room access.
Hormones drive fertility, metabolism, mood, stress, and aging, the body's most important signaling system. Yet their data is almost entirely inaccessible. Today you get a single blood draw at one random moment, but hormones move by the hour, and the pattern is where the meaning lives. HarmonIQ's biosensor uncovers that hidden data, makes it continuous, accessible, and clinically actionable.
A non-provisional patent on our sensor architecture, with core chemistry held as trade secret plus a team out of the CGM industry that has built wearable biosensors at scale before.
$10B TAM $3B SAM $360M SOM
Episodic kits (Oova, Inito, Mira) capture single timepoints. Emerging continuous players (Level Zero, Impli, Biosens8) are early and narrow. We are the first multi-hormone ISF platform built to scale.
Founding team
Mario Sierra
Founder/CEO
Company updates
No updates posted yet.
Follow this company
Get an email when HarmonIQ Biosciences posts an update. No account needed — one click to unsubscribe.
HarmonIQ Biosciences — raising $2.0M
Deck · financials · founder contact